Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program.
Saved in:
| Title: | Final analysis of potential drug-drug interactions between highly purified cannabidiol and anti-seizure medications in an open-label expanded access program. |
|---|---|
| Authors: | Gaston TE; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Division of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA., Bebin EM; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA., Cutter GR; Department of Biostatistics, University of Alabama at Birmingham School of Public Health, Birmingham, Alabama, USA., Grayson L; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA.; Division of Neurology, Birmingham Veterans Affairs Medical Center, Birmingham, Alabama, USA., Szaflarski JP; Department of Neurology, Division of Epilepsy, University of Alabama at Birmingham, Birmingham, Alabama, USA. |
| Source: | Epilepsia open [Epilepsia Open] 2023 Dec; Vol. 8 (4), pp. 1405-1412. Date of Electronic Publication: 2023 Aug 26. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101692036 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2470-9239 (Electronic) Linking ISSN: 24709239 NLM ISO Abbreviation: Epilepsia Open Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2470-9239 |
|---|---|
| DOI: | 10.1002/epi4.12815 |
